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Introduction

Abstract

Progress
in the treatment
of cancer has been
hampered
by the inherent
ability of tumor cells to
metastasize.
Metastasis is a complex, multi-step
process that is poorly understood.
Tumor cells must invade the extracellular
matrix
(ECM) at multiple
stages during the metastatic
process.
Tumor cell invasion of the ECM has been proposed
to be a three
step process:
(1) attachment
to endothelial
cells and
the ECM, (2) proteolytic
digestion
of the ECM, and
(3) locomotion
(Liotta et al., 1983).
Although the
role of tumor cell locomotion in invasion and metastasis has been studied (Werling et al., 1986; Raz and
Ben-Ze'ev,
1987; Maslow, 1987; Verschueren
et al.,
1988), the specific
step of migration
needs to be
clearly
distinguished
from the overall process
of
metastasis
(Grimstad,
1987, 1988).
The modified Boyden chamber has been a major
instrument
to quantitate
migration
(Varani et al.,
1978; Nabeshima et al., 1986; Fliegel et al., 1985;
1986; Wewer et al., 1987). Membrane invasion culture
system
(MICS) chambers,
(Gehlsen
et al., 1984),
Transwell
chambers
(Repesh,
1989) and numerous
other chambers
that are modifications
of the Boyden
chamber have been used to evaluate migration
and
invasion.
Early studies on quantitating
migration in
the Boyden chamber (Varani et al., 1978) have now
evolved to analyze the effect on migration by various
chemotactic
agents
(Orr et al., 1978; Lam et al.,
1981; Thorgeirsson
et al., 1982; Varani et al., 1985),
haptotaxic
agents
(McCarthy
and Furcht,
1984;
McCarthy et al., 1986) and drugs (Spiro and Mundy,
1980; Daughaday
et al., 1981).
Light microscopy
(Thorgeirsson
et al., 1982), radiolabelling
(Repesh,
1989) and scanning
electron
microscopy
(AlbrechtBuehler,
1986) have been used to evaluate
cell
locomotion and migration.
Agents that interfere
with either microtubules
(e.g.,
colchicine
or taxol) or microfilaments
(e.g.,
cytochalasin
B) inhibit tumor cell migration
( Spiro
and Mundy, 1980). Raz and Geiger (1982) speculated
that the role of the cytoskeleton
was not only active
in migration,
but also in the tumor cell's ability to
deform and make/break
intercellular
contact.
Retinoic acid (RA) and butyric
acid (BA) inhibit growth
and induce differentiation
of tumor cells ( Nordenberg
et al., 1986; Roberts and Sporn, 1984) as well as affect the cytoskeleton
(Lehtonen
et al., 1983; Ng et
al., 1985; Borenfreund
et al., 1980).
In our investigation,
we quantitated
by scanning
electron
microscopy
( SE M)
the
migration
of

Retinoic acid (RA) and butyric
acid (BA) were
investigated
for their effect on in vitro migration of
highly metastatic
murine B16a meTanoma cells.
These
potential
antitumor
agents are known to alter the
cytoskeleton.
Our initial studies determined
the 72 h
cytostatic /c totoxic concentration
of RA (1 X 10-6 M
I> 1 X 10- M) and BA (1.5 mM) / > 2.0 mM). Cytostasis
by RA and BA was confirmed by autoradiography and radioisotope
incorporation.
For migration
assays,
cells were plated on 3 and 5 µm diameter
pore polycarbonate
membranes.
Complete media was
added containing
RA or BA at time of plating.
For
BA pretreatment
studies,
BA was added to cells for
72 h prior to plating cells in fresh BA on the membranes.
Top and bottom surfaces
of the membranes
were examined after 72 h of incubation
by scanning
electron
microscopy.
Al though RA and BA induced
cells on top of the membrane to change morphology
as shown by phase, transmission
and scanning
electron microscopy,
only BA enhanced the deformability
of cells to allow for passage through the 3 µm diameter pores.
Butyric
acid enhanced
migration
through
3 µm diameter
pore membranes
by 511%.
For 5 µm diameter
pore membranes,
55.2% of the
plated number of untreated
early passage cells migrated to the bottom surface as compared to 5 7. 3 % for
BA-treated
cells and 14.9% for RA-treated
cells.
However, if cellular proliferation
over the 72 h period was factored in, BA increased
migration by 456%
over the controls
and pretreatment
of cells with BA
for 72 h prior to plating
increased
migration
by
893%. Without considering
proliferation,
RA inhibited
migration by 75% over controls.
The decrease in migration observed
in RA-treated
cells was due to an
inhibitory
effect on cellular migration and a decrease
in proliferation.
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untreated,
RA-treated,
and BA-treated
B16a cells
through porous polycarbonate
membranes.
We calculated migration rates by SEM. The migration rate of
B16a cells was defined as the number of cells adhering to the bottom of a polycarbonate
membrane divided by the number of cells plated.
The number of
cells adhering
to the bottom of the entire membrane
was extrapolated
from the number of cells counted
within 50 random fields as observed by SEM. This
study demonstrated
that RA inhibited while BA increased
the migration rate of B16a cells.
We have
also shown by transmission
electron
microscopy
(TEM) that RA and BA induce changes in the cytoskeleton of B16a cells.
The role of the cytoskeleton
in tumor cell migration is discussed.
Materials

10-5M concentration
of taxol used in the migration
assay was the same concentration
used in the motility assay of Keller and Zimmermann (1986). Viability
and cell number were determined
at 72 h by the trypan blue dye exclusion test and the hemacytometer,
respectively.
Incorporation
of 3H Thymidine by BA-treated
Cells
The incorporation
of 3H-thymidine
was determined by autoradiography
and beta scintillation
according
to the method of Ryan et al. (1987).
For
autoradiography,
untreated
and BA-treated
(1.5 mM)
were incubated
for 72 hon acid-washed
glass slides.
One µCi/ml of 3H-thymidine
(specific
activity
6. 7
Ci/mM) was added 24 and 54 h after the start of incubation.
Slides were washed with cold 0 .1 M
thymidine
in phosphate
buffered
saline (PBS) and
fixed for 2 min at room temperature
in freshly
prepared
4% paraformaldehyde
in PBS (pH=7 .4).
Slides with unlabelled
cells were run as a control.
Slides were washed with PBS, dehydrated
in ethanol
and air dried.
They were coated with Kodak NTB2
emulsion, dried overnight
in the dark, placed in a
light tight box and refrigerated
for 2, 4, and 6 days.
Slides were developed in D19 developer
for 5 min.
Each slide was rinsed in 1 % acetic acid ( 30-60 sec)
and fixed.
Finally,
slides were rinsed in running
water and stained with Giemsa (Fisher Diagnostics,
Orangeburg,
NY). Analysis of 3H-thymidine
incorporation for autoradiography
was done by (1) counting
the number of labelled and unlabelled
cells, and (2)
measuring the percent area of labelling in cells using
a PGT digitizer.
Background
was defined as ~ 25
grains/window
on the PGT digitizer
at a total m!)gnification
of 1550X. The total incorporation
of 3Hthymidine using beta scintillation
was determined
as
follows.
Control and growth inhibitory
concentrations of BA were added in triplicate
24 h after cell
plating.
After 54 h, 1 or 2 µCi/ml of 3H-thymidine
was added for 18 h. Cells were washed with Hank's
Balanced Salt Solution (HBSS) without ca++ or Mg++
and lifted by trypsin/EDTA.
Collected cells were
either harvested
onto glass filter paper or not fil tered.
Aqueous scintillation
fluor (Packard
Instrument Co., Inc., Downers Grove, IL) was added to the
filters and to the unfiltered
cell suspensions.
Counts
per minute were determined
by liquid scintillation
spectrophotometry.
Incorporation
of 3H-IdUR by RA-treated
Cells
The mcorporat1on
of 3H-IdUR was determined
by autoradiography
and beta scintillation
as in the
above section with the following exceptions:
( 1) for
both autoradiography
and beta
scintillation
one
µCi/ml of 3H-5-Iodo-deoxyuridine
(Amersham Inc.,
Arlington Hts., IL) (specific activity of 5 Ci/mM) was
added at 54 h after the start of incubation;
(2) the
cytostatic
concentration
of RA was used for both
autoradiography
and beta scintillation;
( 3) analysis of
incorporation
of 3H-IdUR by autoradiography
was
done only by counting labelled and unlabelled
cells;
and (4)cellular
suspensions
were filtered
for beta
scintillation.
Migration Assay
The methodology
in this investigation
was a
modification
of the migration assay of Varani et al.
(1978).
We utilized
either the Transwell
chamber
system
(Costar,
Cambridge,
MA) or a diffusion
chamber
(Persky
and Grganto,
1987).
Transwell
chambers have a well within a well design containing
a 3 or 5 µm diameter pore polycarbonate
membrane

and Methods

Cell Culture
Mur1ne B16a (amelanotic)
melanoma cells, also
referred
to as B16-F10a cells, were obtained
from
the DCT Tumor Repository
(NCI Frederick
Cancer
Research Facility,
Frederick,
Maryland).
Cells were
cultured in Eagle's Minimum Essential Medium (MEM)
(Gibco, Grand Island, NY) containing Hank's salts and
1-glutamine
supplemented
with
sodium
pyruvate
(Sigma, St. Louis, MO), 10% non-heat
inactivated
fetal calf serum (FCS) (Gibco),
1% penicillin
Gstreptomycin
sulfate-amphotericin
B (Fungizone)
(Gibco), MEM non-essential
amino acids (Gibco), sodium bicarbonate
(Sigma), and Hep es (Sigma).
The
final pH of the medium was 7. 3. Cells were cul tu red
in a humidified incubator
(37°C in 5% CO2) and were
refed every three days.
Cells were subcultured
with
trypsin/EDTA
(Sigma)
during
the log phase
of
growth.
All other parameters
were standard.
The
tail vein experimental
metastatic
assay of Poste et
al. (1980) was used to verify the lung-colonizing
potential
of the cells in C57BL6 mice.
The metastatic potential
of the cells was confirmed prior to
initiating
the
migration
assays
and also after
completing
all assays.
In Vitro Growth Curves of RA, BA, Calf Serum, and
Colch1cme-Treated
Cells
Cells were plated m triplicate
for each experiment at a concentration
of 150,000 cells per 35 mm
dish
(50,000 cells per
ml).
24 h later,
RA (OM,
10-8M, 10-7M, 10-6M and 10-5M in complete medium
containing
0.1% ethanol), BA (0.0mM, 0.lmM, 0.2mM,
0.5mM, lmM, 1.5mM and 2mM in phosphate buffered
saline),
10% calf serum (CS), and colchicine
(OM,
10-8M, 10-7M and 10-5M in complete medium containing 0.1% ethanol) were added independently.
Retinoic acid and colchicine were obtained from Sigma,
BA from J. T. Baker (Phillipsburg,
N .J.) and CS from
Gibco. Different concentrations
of RA were prepared
under minimal light conditions
according
to the method of Lotan and Nicolson (1979).
Retinoic acid
was dissolved
in 100% ethanol to produce a series of
stock solutions
from 10-l to 10-5 M, and stored for
up to a week at -60°C.
Stock solutions were diluted
1: 1000 with complete medium prior to usage.
Two
sets of controls
were run.
One control contained
complete medium. The second control contained
0 .1 %
ethanol (the final ethanol concentration)
in complete
medium.
The FCS was exposed to ultraviolet
light
for 1 h in order to destroy vitamin A activity
( Ng et
al., 1985).
The concentration
of RA in the control
medium was therefore
considered
to be 0 M. The
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(10 µm in thickness)
in the inner well.
Trial 1
In the first investigation,
polyc arbon ate membranes with 3 µm pores were utilized.
Cells
were plated at least in triplicate
in the upper wells
of the Transwell chambers (70,000 cells/well;
50,000
cells/well;
and 5,000 cells/well).
Cells were allowed
to attach to the polycarbonate
membranes for 24 h
prior to treatment
with cytostatic
concentrations
of
RA, BA, colchicine,
or taxol.
Cells were then incubated for three days without refeeding.
Drugs were
not replenished
during the migration assays.
Cytostasis was defined as the concentration
of drug that
inhibited
cell growth without measurable cell death.
The experiment
in which cells were treated with or
without BA (50,000 cells/well)
was quantitated
by
SEM (n=4, 500X). The percent migration was determined from the number of cells counted/field
times
50 (the number of fields counted)
times 15.36 (50
fields at 500X is equal to 1/15.36 of the total surface area).
Colchicine,
RA, and taxol-treated
cells
were qualitatively
examined.
Trials 2 - 4
In the
second
investigation,
quantification
of migration by SEM was done using 5
µm diameter pore polycarbonate
membranes (Nuclepore, Pleasanton,
CA) in diffusion chambers or 5 µm
pore Transwell
chambers.
Migration was evaluated
by counting cells on the bottom surface of the membranes after 18 (Trial 4) and 72 h (Trials 2 and 3) of
incubation.
The number of migratory
cells was determined by counting cells within 50 fields per membrane, each field at 1, 700X. This magnification
was
selected
in order to properly
delineate cell boundaries.
Percent migration was determined by two different methods.
The first method was defined as the
number of migratory
cells counted per field times 50
(the number of fields counted) times 177 .59 (50 fields
at 1700X is equal to 1/177.56 of the total surface
area) divided by 50,000 (the number of cells originally plated).
For the 18 h time period, untreated
and
BA-treated
early passage
(less than six passages)
cells were plated into Tran swell chambers
(50,000
cells/well).
For the 72 h time period, untreated,
BAtreated,
BA-pretreated
(72 h before plating),
RAtreated,
and calf serum-treated
early passage (Trial
2) cells were plated into either the Transwell system
or a diffusion chamber (50,000 cells/well).
The second methodology
for determining
percent
of migration was calculated
only for untreated
and BAtreated cells by incorporating
a proliferation
factor,
Pf, for cellular proliferation
in 35 mm dishes during
the 3 day incubation period.
The two Pf values were
obtained with a hemacytometer
by counting the number of untreated
and BA-treated
cells after 3 days of
incubation.
The Pf values were 777,275 and 177,500
for untreated
and BA-treated
cells, respectively.
This method was thus defined as the number of cells
per 1, 700X field times 50 divided by Pf.
Trial 3
Quantification
of migration was done
on later passage B16a cells (greater than 6 passages).
Untreated,
BA-treated,
and BA-pretreated
(72 h before plating)
cells were plated
into a Transwell
chamber (n=4, 50,000 cells/well).
Scanning Electron
Microscopy
All membranes
were prepared
according
to
standard
techniques
except that the membranes were
air dried instead of critical
point dried.
Briefly,
membranes were washed in 0.2M cacodylate
buffer,
fixed in 2% glutaraldehyde,
and post fixed in 1%
osmium tetroxide.
The membranes were dehydrated,

of Bl6a Cells
air dried, mounted, and sputter coated with gold (27
nm coating; Polaron ESl00 Series II sputter coater).
Membranes were viewed with a JEOL JSM-840A SEM.
Transmission
Electron Microscopy
(TEM)
A prehmmary
ultrastructural
study was undertaken to provide evidence
that RA and BA modify
the cytoskeleton
of B16a cells.
Transmission
electron microscopy
was done according
to the method
of McDonald (1984) and Costar Corporation
(personal
communication)
in order to preserve microfilaments.
Briefly,
a migration assay was run with untreated,
RA-pretreated,
and BA-pretreated
cells in Transwell
chambers.
All steps were run with membranes still
in the Transwell
chambers.
Membranes were fixed
after 72 h with 2% glutaraldehyde
in 50 mM cacodylate buffer
(pH=7 .4) containing
5 mM CaCl2 for 30
min at 37°C.
The membranes were rinsed in buffer
(3X) for 5 min at 37°C and incubated in buffer containing 0.8% K3Fe(CN)5 for 30 min. The membranes
were incubated
in buffer containing
O.5 % OsO4 and
0 .8% K3Fe(CN)5 for 30 min, rinsed in buffer,
and
then rinsed in distilled water (3X). The membranes
were stained en bloc with 2% uranyl acetate (distilled
water) for 60 to 120 min, rinsed in distilled
water
(3X) and then dehydrated
in grades
of ethanol.
Membranes
were
infiltrated
into
resin
(EponAraldite),
cut out of the Transwell inner well, and
polymerized
in blocks at 60°C for several days. Thin
sections
were cut, stained in 1 % uranyl acetate (in
70% methanol)
and lead citrate,
and viewed with a
Hitachi H-600 transmission
electron microscope.
Results
Growth Curves
In vitro growth curves of BA (Fig. 1), RA (Fig.
2), ana colchicine-treated
(Fig. 3) cells were determined by hemacytometer.
Cell viability
for the six
different
treatment
groups (control medium, control
medium + 0.1% ethanol, RA, CS, BA, and colchicine)
as determined
by the trypan blue exclusion test was
always greater
than 90%.
Cells were treated for 72 h with different
concentrations
of BA (Fig. 1).
A concentration
2 mM
BA was found to be cytotoxic
as fewer cells were
found after 72 h (130,500 ± 33,600) than were plated
(150,000).
A concentration
of 1.5 mM BA was not
cytotoxic
yet inhibited proliferation
by 77% ± 6% as
compared to the controls
(0 mM). After 72 h of incubation in 1.5 mM BA, viability
was comparable
to
72 h controls
(0 mM), i.e., 97.3% ± 1.5% and 98.9% ±
0. 3 %, respectively.
The 'cytostatic 'concentration
of
BA was determined
to be 1.5 mM and was used for
all further
cell proliferation
and migration experiments.
It was also observed that the lowest concentration of BA (0.lmM) inhibited proliferation
by 35%.
The cytotoxic/ cytostatic
concentrations
for RA
were determined
to be 1 X 10-5 M/1 X 10-6 M, respectively
(Fig. 2). The cytostatic
concentration
inhibited proliferation
as compared to the O.1 % ethanol
control by 65% and was used for all further cell proliferation
and migration
experiments.
The lowest
concentration
tested (1 X 10-8 M) inhibited proliferation by 50%. The dishes that contained
1 X 10-4 M
concentration
of RA were found to have more viable
cells than 1 X 10-7 M. Since crystals
of RA were
found in the 1 X 10-4 M concentration
medium, we
believe that this concentration
produced
a supersaturated
condition such that the RA was not able to
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Figures 1-3 (to the left).
Dose response curves as
measured by hemacytometer
for BA, RA, and colchicine-treated
B16a cells.
Cells were plated (50,000
cells/ml,
3 ml total) in culture dishes.
Various concentrations
of BA, RA, and colchicine
were added
after 24 h.
Cell number was determined
96 h after
plating.
Dotted line indicates number of cells plated.
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completely dissolve in ethanol.
The addition of O.1 %
ethanol did not affect proliferation
(p < 0.05) (Table
1).
Proliferation
was significantly
inhibited
(p <
0.001) by 59.1% when 10% CS was substituted
for 10%
fetal calf serum (Table 1).
Figure
3 is the growth curve of colchicinetreated
cells.
The cytostatic
concentration
was
determined
to be 5 X 10-7 M.
3H-Thymidine
Incorporation
in BA-treated
Cells
Inhibition of 3H -thymidine
incorporation
by BA
was determined by autoradiography
and beta scintillation.
In the experiments
using autoradiography,
two different
3H-thymidine
incubation
times, 18 h
and 48 h, were used.
Two separate experiments
were
done in which the cells were labelled
for 18 h,
starting
54 h after cell plating.
Unlabelled and labelled cells were counted from twelve different
fields
(average of 125 cells counted/field,
200X) from three
different
slides (two slides from the first 18 h protocol, one from the second 18 h protocol).
Autoradiography revealed that after 18 h 59.1% (standard
error
of mean, SE = 9.3) of the untreated
cells had incorporated
the 3H-thymidine,
while only 32.9% (SE =
0.6) of the BA-treated
cells had incorporated
the
label.
The percent
inhibition
of 3H-thymidine
incorporation
was calculated
tobe 42.0% (SE= 7.1).
Two autoradiography
methods (A and B) were
used for counting cells that were labelled with 3Hthymidine
for 48 h.
For both methods, cells were
labelled 24 h after plating.
For method A, the absolute number of labelled
and unlabelled
cells was
counted.
After 48 h of incubation,
96% of the
untreated
cells were labelled, while 58.5% of the BAtreated
cells were labelled
(data not shown).
The
percent
inhibition
of incorporation
of 3H-thymidine
was calculated
to be 39.1%.
For method B, the
amount of labelling was calculated
on a PGT digitizer
from the percent
of a set area containing
the label
(739.8 µm2, 689X). A total of 53 cells were digitized
for each group, i.e., untreated
and BA-treated
cells.
A minimum of 10 random fields were investigated
for
each group.
The area labelled in untreated
and BAtreated cells was calculated
to be 6.6% (S.D. = 3.2)
and 3.2% (S.D. = 3.7), respectively.
The percent
areas were significantly
different
(p < 0.0001).
Lastly, 3H-thymidine incorporation
for untreated
and BA-treated
cells was measured after an 18 h incubation period by beta scintillation.
The average
percent inhibition of 3H-thymidine
incorporation
was
80% (Table 2).
3H-ldUR Incorporation
in RA-treated
Cells
Inhibition of 3H-ldUR incorporation
by RA was
determined by autoradiography
and beta scintillation.
For the autoradiography,
unlabelled and labelled cells
were counted from 21 (untreated)
or 24 (RA-treated)
different
fields (200X) from three different
slides.
Autoradiography
revealed that 64.5% (SE = 1.58) of
the untreated
cells were labelled after 18 h incubation with 3H-ldUR, while only 29.8% (SE = 1.47) of
the RA-treated
cells had incorporated
the label. The
percent inhibition of 3H-ldUR was calculated
to be
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NUMBER OF CELLS AFTER 72 H OF INCUBATION AS DETERMINED

BY HEMACYTOMETER

cs

UNTREATED

0.1% ETHANOL

10% FCS

484,343.8

445,500.0

429,750.0

175,916.7

42,932.5

67,752.8

41,511.3

20,779.1

4

3

3

3

X

SD
N

Table 1. The means of the untreated
and O.1 % ethanol groups
means of the hemacytometer
counts for 10% FCS-treated
cells
ferent (p < 0.001).

TABLE 2

INCORPORATION

Unfiltered

OF 3tt-THYMIDINE

Control

Unfiltered

10%

were not significantly
different (p > 0. 05).
and 10% CS-treated
cells were significantly

CPM AS DETERMINED BY BETA SCINTILLATION
Filtered

BA

Control

1 µCi/ul

Filtered

BA

2 µCi /ul

x

630,791.60

202,603.80

1,511,300.0

104,845.2

SD

26,879.85

75,799.01

141,570.6

26,684.5

3

3

3

3

N

Table 2.
measured.
harvester.
suspensions

The 3tt-thymidine
incorporation
by untreated
and BA-treated
cells after 18 h incubation
was
Cells were lifted with trypsin/EDTA.
Filtered
cell suspensions
were collected
with a cell
The percent
inhibition
by BA of 3tt-thymidine
incorporation
was 67 .9% for unfiltered
cell
and 93 .1 % for filtered cell suspensions.
The average percent
inhibition
was 80%.

TABLE 3 INCORPORATION OF 3tt-IdUR CPM AS
DETERMINED BY BETA SCINTILLATION
Filtered
X

SD
N

The
dif-

Control

Filtered

18,898.4

5,232.7

2,371.4

1,032.1

3

6

cine (Fig. 8), and taxol (Fig. 9) treatment induced a
flattened
morphology as compared to untreated
cells
whether the cells were grown on plastic or on polycarbonate
membranes.
Colchicine
and taxol-treated
B16a cells on top of the membrane were not as flattened in shape as BA-treated
cells.
The majority of
colchicine
(Fig. 8) and taxol treated cells (Fig. 9)
were covered with blebs.
Retinoic acid induced
a
spindle-shaped
morphology.
The major observation
was that
many more BA-treated
cells
migrated
through 3 µm pore membranes than untreated,
RA,
colchicine,
or taxol-treated
cells.
The experiment
in
which cells were treated with or without BA (50,000
cells/well)
was quantitated
using SEM. The increase
in the percent
migration
induced by BA over untreated controls was calculated
to be 511% (Trial 1,
Table 4).
Migration through the membrane for untreated
(Fig. 4), RA-treated,
colchicine
(Fig. 8) or
taxol (Fig. 9) was < 2% of the original plated number.
Cell plating density,
which ranged from 5,000
to 75,000 cells per well, did not have an effect on
the migration
of untreated
and BA-treated
cells
through the 3 µm pore polycarbonate
membrane (data
not shown).
Later experiments
quantitated
by SEM the migration of untreated
and treated cells through 5 µm
pore diameter membranes after 18 (Trial 4, Table 4)
and 72 h (Trials 2 and 3, Table 4) of incubation.
Both diffusion chambers and Transwell chambers were
used.
Table 4 illustrates
that Transwell chambers
were used for Trials 3, 4, and PBA, RA, CS treatments of Trial 2. Diffusion chambers were used for
the other parameters
of Trial 2.
Trial 2
Using early passage
cells (passage
less than six), an average of 3 .11 control cells/field
( SE = 1.2 2) and 3. 23 BA-treated
cells/field
( SE =
1.13)
were observed on the bottom of the membrane

RA

Table 3.
The 3tt-IdUR incorporation
by untreated
and RA-treated
cells after 18 h incubation was measured.
Cell were lifted with trypsin/EDTA
and the
cell suspension
was filtered
with a cell harvester.
The percent
inhibition
of 3tt-IdUR incorporation
by
RA was 72 .3%.
52 .6%. For the beta scintillation,
the percent inhibition of 3tt-IdUR incorporation
was 72.3% (Table 3).
Migration Assay
The 1mhal experiments
using 3 µm diameter
pore polycarbonate
membranes led to further analysis
and quantification
of migration with 5 µm diameter
pore membranes.
Light microscopy showed untreated
cells grown on plastic
to be heterogeneous
in morphology (round to flat) as well as diverse
in cell
size.
In contrast,
BA-treated
cells were a homogeneous population
of large, flattened
cells.
The morphology of untreated
cells (Figs. 4 and
5), RA-treated
(Fig. 6), BA-treated
(Fig. 7), colchicine-treated
(Fig. 8) and taxol-treated
(Fig. 9) cells
was also evaluated by SEM on both 3 and 5 µm diameter pore polycarbonate
membranes.
In all cases,
cells on the top surface of the polycarbonate
membranes had morphology similar to comparable treated
cells grown on plastic.
Butyric acid (Fig. 7), colchi-
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Figure 4 (at left).
Scanning electron micrograph
of
untreated
cell on the top surface of a 3 µm pore
polycarbonate
membrane after 72 h of incubation.
Figures 5-7 (below and facing page top).
Scanning
electron
m1crographs
of untreated
(Fig. 5), RAtreated (Fig. 6), and BA-pretreated
(Fig. 7) cells on
the top ("a") and bottom ("b") surfaces of 5 µm diameter pore polycarbonate
membranes after 72 h of
incubation.
Note the pseudopod
coming out of a
pore in Figures 5 and 6 (arrow).
Figures 8-9 (facing page middle).
Scanning electron
m1crographs of colchicine
and taxol-treated
cells on
the top surface of 5 µm diameter pore polycarbonate
membranes after 72 h of incubation.
Bars
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(Table 4).
The number of cells per field initially
suggest no significant
difference
in migration
between untreated
and BA-treated
cells.
However,
these numbers do not take into account the partial
cytostasis
induced by BA. If migration rates were
formulated to incorporate
cellular proliferation
(Fig.
1) during a three day incubation
period, BA-treatment enhanced migration by 456% over controls
(p <
0.015) (Table 5). The migration of BA-treated
cells
using 10% FCS was 192% greater than untreated
cells
using 10% calf serum (p < 0.04) (Trial 2, Table 4).
A further enhancement
of migration was induced by
BA if cells were pretreated
for 72 h with BA before
plating.
Pretreatment
increased migration over nonpretreated
BA-treated
cells by 196% (p < 0.005) and
similarly increased
migration over untreated
cells by
403% (p < 0.02) (Trial 2, Table 4). If 72 h migration
rates were formulated
to incorporate
proliferation,
the rate for the BA pretreated
cells was 893% (p <
0. 001) greater than untreated
cells (Table 5). There
was no significant
difference
in migration in the 18
h incubation
period
between
untreated
and BAtreated
cells (Trial 4, Table 4).
In contrast,
the
migration of RA-treated
cells during the 72 h incubation period was decreased
by 75% (p < 0.03) as
compared to untreated
cells, and decreased
by 53%
compared to cells treated with calf serum (p < 0.005)

of Bl6a Cells

(Trial 2, Table 4). The level of significance
between
the migration rates of 10% CS-treated
cells and 10%
FCS-treated
(CO) cells was p < 0.1.
Trial 3
Migration was quantified
using later
passage B16a cells.
The methodology above was used
to quantitate
migration of untreated,
BA-treated,
and
PBA-treated
cells (n = 4). The percent migration of
untreated
cells was calculated
to be 3. 72% of the
plated number.
Again, we found that BA or PBA increased
migration by 438% and 919%, respectively,
over the untreated
controls
(p < 0.03, p < 0.005).
Transmission
Electron
Microscopy
The analysis
of the cytoskeleton
of untreated,
RA-treated
and BA-treated
B16a cells was a qualitative TEM study.
Analysis of untreated
B16a cells
found two distinct
cytoskeletal
phenotypes.
Cells
that were not visibly attached to the substrate
displayed few microtubules
and intermediate
filaments.
Microfilaments
were visible only along cell margins.
Cells that were attached to the substrate
displayed a
disorganized
microtubule
and intermediate
filament
system.
Microfilaments
were found in the cortical
areas of the cytoplasm
(Fig. 10).
In contrast
to
untreated
cells, RA and BA treatment
altered
the
structure
of the cytoskeleton.
Retinoic acid-treated
cells displayed
parallel
arrays of microtubules
and
intermediate
filaments
(Fig.
11).
Less cortical
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MACNIFl~ATIQN

MEAN#
OF~ELLS

% MIGRATION

% CHANCE

IN MIGRATION

SICNIFICAN~E
LEVEL@

72 h

3µrn

Control

4

SOOx

0.82 ± 0.02

1.26

100

72 h

3µrn

BA

4

SOOx

4.19 ± 0.62

6.42

+511

72 h

5µrn

Control

5

1700x'

3.11 ± 0.89

55.23

100

72 h

5µrn

BA

6

1700x'

3.23 ± 0.72

57.36

+ 104

72 h

5µrn

PBA

5

1700x'

6.32 ± 0.19

74.69

+203

0.02

72 h

5µrn

RA

5

1700x'

0.79 ± 0.15

14.03

-75

0.03

72 h

5µrn

cs

5

1700x'

1.68 ± 0.18

29.84

-54

0.1

72 h

5µrn

Control

4

1700x'

0.21 ± 0.04

3.73

100

72 h

5µrn

BA

4

1700x'

0.92 ± 0.17

16.34

+438

0.03

72 h

5µrn

PBA

4

1700x'

1.93 ± 0.23

34.27

+919

0.005

18 h

5µrn

Control

3

1700x'

1.07 ± 0.21

19.00

100

18 h

5µrn

BA

3

1700x'

1.16 ± 0.30

20.60

108

0.013

EARLY P ASSACE
#2

LATE P ASSACE
#3

EARLY P ASSACE
#4

N.S ........

• The 1700x magnification was used to delineate cell boundaries. Care was taken not to overlap between cells.
" Refer to proliferation table, Table 5.
"' N.S. = not significant.
Table 4. The migration of B16a through 3 µm and 5 µm diameter pore polycarbonate
membranes.
There was
a sigmficant
difference
in the migration through a 3 µm diameter pore membrane between untreated
and BAtreated cells (p < 0.013) (Trial 1). In contrast,
there was no significant
difference
between untreated
and
BA-treated
early passage cells (Trial 2), but there was a significant
difference
between untreated
and BAtreated late passage cells after 72 h incubation
(Trial 3). Interestingly,
there was a significant
increase
in
migration of BA-pretreated
early passage cells as compared to control and BA-treated
cells (p < 0. 02, p <
0.005 respectively,
Trial 2). There was also a significant
decrease
in migration of RA-treated
cells as compared to control and calf serum-treated
cells (p < 0.03, p < 0.005 respectively).
Lastly, there was no significant difference
between untreated
and BA-treated
cells after 18 h incubation.
This table includes percent migration and percent change in migration.
The percent change in migration of untreated
cells was considered
to be 100%.

Sample

Number

1
2
3
4
5
6
N
X

SD
SE
% mig.

Control

(CO)

Butyrate

0 .000380
0.000122
0.000185
0.000257
0.000053

(BA)

0.001830
0 .000490
0 .000500
0.000750
0.001008
0.000873
6
0.000908
0 .000495
0.000020
456

5
0.000199
0.000126
0.000056
100

Pre-butyrate

(PBA)

0 .001630
0 .001980
0.001770
0.001740
0.001770
5
0.001778
0.000127
0.000057
893

Table 5. The migration of control, BA-treated,
and BA-pretreated
cells after 72 h incubation
with a proliferation factor incorporated
into the migration rate.
The migration value was defined as the number of cells per
field times 50 divided by the final hemacytometer
cell population
after 72 h incubation
(Fig. 1). There was a
significant
increase
in migration of BA-treated
and BA-pretreated
cells as compared to control cells (p <
0.015, p < 0.001, respectively).
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microfilaments
were seen with wider focal adhesion
contacts
than in untreated
cells.
Butyric
acidtreated cells also displayed parallel arrays of microtubules and intermediate
filaments oriented along the
longitudinal
axis of the cells.
An extensive cortical
microfilament
network was also seen (Fig. 12). This
preliminary
ultrastructural
study supports
the evidence presented
in the literature
that RA and BA
alter the structure
of the cytoskeleton.
Discussion
In this investigation,
BA enhanced while RA decreased the migration of B16a cells through 3 and 5
µm diameter pores.
Migration of untreated
and RAtreated cells through 3 µm pore membranes was negligible ( < 2% of cells plated).
In contrast
to untreated
cells, treatment
with BA resulted
in a 511%
increase
in migration through 3 µm diameter pores.
The 3 µm diameter pore is near the minimum 1 - 2
µm pore
size that
allows passage of B16 cells
Figure 10-12. Transmission
electron micrographs
of
untreated
(Fig. 10), RA-treated
(Fig. 11), and BAtreated cells (Fig. 12). The untreated
cell (Fig. 10)
displays a disorganized
microtubule and intermediate
filament system with microfilaments
in the cortical
area of the cytoplasm.
The RA-treated
cell (Fig. 11)
shows an organized
microtubule
and intermediate
filament system with less cortical
actin than untreated cells. The BA-treated
cell (Fig. 12) displays
an extensive
system of parallel
microtubules
and a
large amount of cortical
actin.
(Bar = 0 .5 µm).
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(Tullberg and Burger, 1985). Untreated early passage
(less than 6 passages)
cells migrated significantly
through 5 µm diameter pores ( 55 .1 %) . The effect of
BA on the percent
change of migration
through 5
µm pores was not as pronounced
as through 3 µm
diameter pores (104% vs 511% migration, respectively).
On the other hand,
RA-treated
cells migrated
through 5 µm pores at 14.0%, i.e., 75% less than untreated cells.
It was important to determine the cytotoxic/cytostatic concentrations
of RA and BA since they vary
from cell line to cell line (Reese et al.,
1985;
Kyritsis et al., 1984; Lotan and Nicolson, 1979). The
use of non-cytotoxic
drug concentrations
in in vitro
migration assays is important since cytotoxicTiy
will
mask enhancement
or inhibition of migration ( Mareel
and DeMets, 1984).
We used hemacytometer
counts
to demonstrate
that RA and BA decreased
proliferation during the three day incubation
period.
We
used autoradiography
and beta scintillation
to show
that RA and BA also inhibited
the incorporation
of
3H-thymidine
and 3H-ld UR.
Both RA and BA have
been shown to inhibit proliferation
in various tumor
cell lines in the Gl phase of the cell cycle (Roberts
and Sporn, 1984; Thorgeirsson
et al., 1984).
In our study, phase microscopy
and SE M revealed morphological
changes in RA and BA-treated
cells.
How these changes are related to migration is
not known.
The untreated
cell population on top of
3 and 5 µm pore membranes is heterogeneous
(Figs.
4 and 5a). There are, however, more flattened cells
on top of 3 µm pore membranes
than 5 µm pore
membranes.
Concomitantly,
bottom surfaces of 5 µm
pore membranes
are dominated by flattened
cells.
We conclude that increasing
the pore size from 3 to
5 µm allowed more flattened
cells to migrate to the
bottom surface.
Rounded-up
cells, i.e., mitotic cells,
do not migrate.
It is therefore
not surprising
that
incubation
with BA, which enhances cell flattening,
increases
cell migration.
The morphology
of RAtreated
cells differs from either untreated
or BAtreated cells.
The RA-treated
cell population
consisted of spindle to flattened
shaped cells.
Various
methods have been used to quantify
motility (Volk et al., 1984; Keller and Zimmermann,
1986), deformabilty
(Ochalek
et al., 1988) and to
correlate
these properties
to metastatic
potential.
Methods used to quantify motility include time lapse
photography
(Keller and Zimmermann, 1986) and the
phagokinetic
assay (Volk et al., 1984).
Data from
the above experiments
have in some cases been found
to be in direct conflict with data from migration assays (Spiro and Mundy, 1980). Our experimental
protocol emphasizes that migration incorporates
both ac tive cellular
deformabilty
and motility (locomotion)
(Daughaday
et al., 1981).
Migration is therefore
defined as the net summation of cellular deformability and motility.
Microtubule
(MT) inhibitors,
e.g.,
colchicine,
and microfilament
(MF) disrupting
agents,
e.g., cytochalasin
B, inhibited the migration of tumor
cells in a micropore filter system (Spiro and Mundy,
1980) even though cell motility was enhanced ( Keller
and Zimmermann,
1986).
The decreased
migration
seen with microtubule
inhibitors
may be due to reduced cellular
deformability
(Ochalek et al., 1988).
Retinoic acid is not a microtubule
inhibitor,
so the
decrease in migration of RA-treated
cells may be due
to its affecting
motility rather than deformability.
In contrast,
since the percent increase in migration

of early passage BA-treated
cells through the 3 µm
diameter pore membrane is greater than through the
5 µm pore membrane, BA may be affecting
deformability rather than motility.
Retinoic acid and BA are being investigated
as
potential antitumor-antimetastatic
agents,
Studies on
various
cell
lines
(Roberts
and
Sporn,
1984;
Thorgeirsson
et al., 1984; Ryan et al., 1987), including the B16 melanoma cell line (Lotan and Nicolson,
1979; Nordenberg
et al., 1986) have stressed
the effect of RA and BA on growth inhibition
and differentiation.
The change in morphology in these cell
lines has been linked to a change in the cytoskeleton
(Lehtonen et al., 1983; Ng et al., 1985; Altenburg et
al., 1976; Borenfreund
et al., 1980).
The role of the cytoskeleton
in migration
has
been demonstrated
by microtubule
inhibitors
(e.g.,
colchicine,
vinblastine)
and microfilament
inhibitors
(e.g., cytochalasin
B) (Spiro and Mundy 1980). These
inhibitors
reduce migration.
Both RA and BA have
been shown in various tumor cell lines to increase
the formation of microfilaments
and vinculin plaques,
and to reorganize
vimentin
intermediate
filaments
(Lehtonen et al., 1983; Ng et al., 1985; Altenburg et
al., 1976; Borenfreund
et al., 1980).
We also observed by TEM an increase in microtubule and microfilament organization
in B16a cells.
Retinoic acid
and BA induced changes in the cytoskeleton
appear
to be similar, although the surface morphology and
shape of RA or BA-treated
cells differ as examined
by phase contrast
microscopy
and SE M.
Subtle
changes in the cytoskeleton
may induce migration of
BA-treated
cells while inhibiting
the migration
of
RA-treated
cells.
Butyric acid may have a role in
increasing
the amount of acetylated
a-tubulin
(Grant
et al., 1987) thus contributing
to the stabilization
of
microtubules
(Piperno et al., 1987).
The role of cellular migration in invasion and
metastasis
needs further investigation.
The Transwell system has merit for both migration and invasion assays.
Various investigators
have studied invasion by using porous polycarbonate
membranes coated
with a reconstituted
basement membrane (Matrigel)
(Albini et al., 1987; Hendrix et al., 1987; Repesh,
1989).
An increase
in migration of tumor cells in
vitro has been linked to enhanced invasion in vitro
(Grlmstad,
1987; Verschueren
et al., 1988). However,
enhanced
in vitro migration of tumor cells may not
necessarily
lead to increased
metastasis.
Grimstad
(1988) found that hypermotile
selected fibrosarcoma
cells were less metastatic
than the original parent
population.
Mohler et al. (1988) found, in contrast,
a positive correlation
between metastatic potential of
Dunning R-3327 rat prostatic
adenocarcinoma
cells
and motility.
Invasive cells that form specialized
pseudopodia
have been interpreted
by Kramer et al.
(1986) to form adhesion
contacts
with the matrix.
We observed that migratory cells (e.g., Fig. 5b) also
form pseudopodia
when passing through 5 µm diameter pores.
In addition,
we have observed by TEM
focal adhesion contacts
(not illustrated).
Cell motility has been linked to various parts of
the cell cycle in 3T3 fibroblasts
(Thurston
and
Palcic,
1987).
Thurston and Palcic ( 1987) found a
peak in the rate of cell movement in G2 and a significant increase in the average rate of movement as
cells transit
from Gl to S phase.
The significance
of their data, which was obtained on 3T3 cells, as
applied to a tumor cell system is not known.
Since
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RA and BA block entry into the S phase of the cell
cycle (Roberts and Sporn, 1984; Thorgeirsson
et al.,
1984), Thurston and Palcic's
data may not be applicable.
Thurston and Palcic (1987) also found a weak
correlation
between the rate of cell motility and the
rate of cell proliferation.
It is extremely
important
to emphasize that a decrease
in proliferation
is not
sufficient
to explain an increase in migration of BAtreated
cells.
A 5 X 10-5 M concentration
of RA
inhibits both proliferation
and migration.
Calf serum
(CS) does not have as many of the growth factors
that are in fetal calf serum.
Calf serum was found
to inhibit cell proliferation
by 59.1% as compared to
10% FCS (Table 1).
The migration
of CS-treated
cells is also significantly
decreased from the controls
(p < 0.1) and BA-treated
cells.
The migration of
calf serum-treated
cells, however, is significantly
greater
than the RA-treated
cells
(P < 0.005).
Therefore,
we conclude that the decrease
in migration produced
by RA was due to both an inhibitory
effect on cell migration and a decrease in proliferation.
A purely speculative
explanation
for the antimigratory
effect of RA is that changes in glycoproteins found on the cell surface may influence migration (Lotan et al., 1987 a,b; Couch et al., 1987,
1988).
The migration
rates
for untreated
and BAtreated early passage cells were similar (Table 4).
However, if the decrease of cellular proliferation
by
BA is included
in defining migration,
the enhancement of migration
by BA is significant
(Table 5).
Hendrix et al. (1985) have stated that cells which
invaded the amnion had similar proliferation
rates as
cells which did not invade.
The observation
that migration by preincubated
BA-treated
cells was significantly different from untreated
and BA-treated
cells
suggests that further changes occur in the phenotype
of these cells after 3 days.
Tumor cell migration
has been investigated
in vitro using short time periods (4-18 h) (Varani el: aC;7.985; Nabeshima et al.,
1986; Grimstad,
1988).
It is questionable
whether
four hours is long enough to quantitate
migration in
this or any other assay.
Perhaps such a short period
does not adequately
reflect the in vivo condition.
We noted that there was no sign1ficant
difference
between the migration
of untreated
and BA-treated
cells at 18 h (even if 18 h proliferation
data were
used in the calculations,
data not shown).
Cells
treated
for 72 h with BA before plating show a significant
increase in migration (greater than both the
untreated
and BA-treated
cells) in a three day assay
(Tables 4 and 5). It would be of interest to pretreat
cells with BA or RA for 72 h prior to an 18 h
migration assay.
In summary, RA and BA warranted investigation
for two main reasons.
First, these two drugs can be
less host toxic and less mutagenic than conventional
chemotherapeutic
drugs when administered
at cytostatic concentrations.
Second, the effects of RA and
BA on the individual
steps of the metastatic
cascade
are only beginning
to be known.
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Discussion

R.Lotan:
It would have been interesting
if a low
metastatic
variant
had been used in the migration
assay.
Authors:
This is true, but the objectives
of this
project are to evaluate the effect of two drugs on a
highly metastatic
cell line.
This project is part of
an overall investigation
that will evaluate the effect
of RA and BA on viability,
proliferation,
migration,
invasion, and metastasis.
Since the human amnionic
basement
membrane (HABM) assay of Liotta et al.
(New method for preparing
large surfaces of intact
human
basement
membrane
for tumor
invasion
studies.
Cancer Letters,
11: 141-152, 1980) is being
used as one of the invasion assays,
and since the
HABM assay is only valid for highly invasive cells
(Welch, DR. 1986, Discussion of the suitability,
availability and requirements
for in vivo and in vitro
models of metastasis.
In: Cancer Metastasis,
Experimental and Clinical Strategies;
DR Welch, BK Bhuyan,
and LA Liotta (eds.).
Alan R. Liss, Inc., 135), low
metastatic
cells were not used.

with Reviewers

R. Lotan:
What is a diffusion chamber?
Authors:
Our diffusion chamber is a modification
of
the Membrane Invasion Culture System ( MICS) chamber (Gehl sen et al., 1984; text reference).
Figure 13
is a 14 well MICS chamber.
Our diffusion chamber
is similar to the MICS chamber except that the diffusion chamber has 45 wells.
In the migration
assays, complete medium with or without a drug is
added to the lower wells.
The polycarbonate
membrane is placed between an upper and lower chamber,
creating
45 separate
upper and lower wells.
Cells
are then added in complete medium, with or without
a drug, to the upper wells.
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of Bl6a Cells

M.J .C. Hendrix:
Is the rapid rate of biological degradation
of retinoic acid by tumor cells similar for
butyric acid?
If not, what bearing would this information have on the data generated
in this study?
Authors:
To our knowledge
the rate of biological
degradation
of BA by tumor cells has not been reported.
The incorporation
of tritiated
RA by murine
S91 melanoma cells has been reported
to be rapid
during the first 15 min. Tritiated
RA is incorporated
much more slowly after this initial 15 min time period (Lotan et al., Characterization
of retinoic
acidinduced alterations
in the proliferation
and differentiation of a murine and a human melanoma cell line
in culture.
Ann N.Y. Acad Sci 359: 150-170, 1981).
In addition,
S91 and B16 melanomacells,
when grown
in 10-5 M RA for six days and then refed in RA-free
medium, continued
to proliferate
at a reduced
rate
for 24-48 h. However, after 3 days of incubation
in
RA-free medium, the growth rate of previously
RAtreated
cells returned
to that of the control cells
( Lotan et al., Characterization
of the inhibitory
effects of retinoids
on the vitro growth of two malignant murine melanomas. JNCI 60: 1035-1041, 1980).
This reversible
inhibition of growth of various tumor
cell lines has been reported
by others using BA
(Prasad
and Sinha, Effect of sodium butyrate
on
mammalian cells in culture:
a review. In Vitro 12:
125-135, 1976). We have observed reversible
changes
in morphology of RA and BA-treated
B16a cells after
removal of the drug from the medium.
Therefore,
despite a rapid incorporation
and rapid degradation
of RA (and possibly BA) these drugs remain effective
in changing morphology and inhibiting growth beyond
the 72 h experimental
time period.

C
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8

Figure 13: MEMBRANE INVASION CULTURE SYSTEM
(MICS; Pat Pending 84-027-1)
(A) Top Plate;
(B) Bottom Plate;
(C and E) Upper Wells; (D and F) Lower Wells;
( G) Polycarbonate
Membrane;
(H) Washer;
(I) Bolt.
(Redrawn with permission
from Hendrix et al., 1985).
M. J.C. Hendrix:
It is very difficult to derive significant statistical
information
from Table 4 when less
than seven cells are presented?
Authors:
As a purely statistical
question,
this is a
vahd criticism.
Table 4 presents
data obtained from
50 fields at 1700X. Data could have been presented
at lower magnifications,
e.g., 500X.
At 500X, the
exact same quantitated
surface area would have provided 15 fields (1,700 divided by 500 = 3.4; 50 divided
by 3 .4 = 15). The mean number of cells for Table 4
would therefore be 3.4X greater.
We chose to present the data at 1, 700X because we could positively
distinguish
individual
cells at higher magnification.

M.J.C. Hendrix:
Was scanning electron microscopy
the only techmque used to quantitate
the tumor cells
on the polycarbonate
membranes?
If so, what precautions were taken to insure that the entire filter
was examined with SEM? Weren't the samples quite
large to handle?
Authors: Our initial attempts to quantitate
cells by
light microscopy
were unsuccessful
because we were
not able to distinguish
cells above, in, and below the
membrane.
Radioisotope
labelling of cells was also
attempted,
but difficulties
were encountered
in
removing
BA-treated
cells from the polycarbonate
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membranes.
Even a 20 min trypsin/EDTA
incubation
failed to completely
remove the BA-treated
cells
from the membrane.
The entire membrane was observed by SEM. Care was taken to select 50 random
fields to quantitate
migration.
Samples were not too
large to handle.
On the contrary
the small size of
the membranes permitted
three complete Transwell
membranes to be loaded at one time into the SEM.

Reviewer IV: Is the rate of proliferation
the same
between cells grown on polycarbonate
membranes as
cells grown on tissue culture treated plastic?
Authors:
Yes.
We have previously
determined
that
there is no significant
difference
between B16a cell
proliferation
rates for cells grown on plastic dishes
versus polycarbonate
membranes.
We quantified proliferation
by plating cells into Transwell chambers
(50,000 cells/well)
and into a 24 well plate (Corning)
(50,000 cells/well).
Each experiment was done in triplicate and the number of cells determined
after 72
h by hemacytometer
count.

M.J .C. Hendrix:
Do the authors propose that SEM
offers a universal
quantitation
approach
for tumor
cell invasion
that supersedes
currently
available
technology?
Authors:
Scanning electron microscopy
is an accurate and reproducible
method for quantifying
migration and invasion.
SEM allows visualization
of top
and bottom membrane surfaces and permits observation of individual
cells.
SEM does not have the
depth of field resolution
problem that is associated
with light microscopy.
SE M is but one method to
quantitate
cell invasion and migration.

Reviewer IV: Why did the authors use two different
radioisotopes
to determine proliferation
rates?
Authors:
After completing the BA experiments
with
3tt-thymidine,
we changed radioisotopes
to 3tt-IdUR.
The irreversible
binding property
of 3tt-IdUR makes
it a better radiolabel
than 3tt-thymidine
(Fidler,
I.
Metastasis:
quantitative
analysis of distribution
and
fate of tumor emboli labelled with 125I-5-Iodo-2'
deoxyuridine.
JNCI, 45: 773-782, 1971). Since BA had
already been ghown to produce a significant
inhibition of 3tt-thymidine
incorporation,
we thought it
would not be necessary
to repeat the BA experiments
using 3tt-IdUR.

R. Lotan:
Why is it probable that increasing
the
pore size from 3 µm to 5 µm allows "flattened"
cells
to migrate?
Authors:
We have shown that the migration of early
passage untreated
B16a cells through 5 µm diameter
pore membranes is 66% greater
than the migration
through 3 µm diameter pore membranes (Trials 1 and
3, Table 4). We have observed that cells on the top
surface
of the 3 µm diameter
pore membrane are
heterogeneous
in shape and contain flattened
cells.
In contrast,
the heterogeneous
population of cells on
top of 5 µm diameter pore membranes have few flattened cells.
It appears that the majority of cells on
the bottom surface of the 5 µm pore membrane are
flat in shape.

Reviewer IV: The methodology of choice for determmmg cytotoxic/ cytostatic
effects of drugs is the
double-label
growth assay.
Why did the authors not
use this technique?
Authors:
We agree that the double label growth assay is a preferred
method to quantitate
viability
and
proliferation
in drug studies.
Although the trypan
blue exclusion method is less sensitive, it did provide
cytotoxic/cytostatic
data that was statistically
significant.

R. Lotan:
It is possible
to dehydrate
tissues
for
SEM with alcohol instead of acetone that would have
allowed you to critical
point dry the specimens
instead of air drying them.
Also, the membranes can
be cut out of the plastic
well and processed
separately.
Authors:
Despite the cracking
produced by air drying, problems were not encountered
in quantitating
cells.
The cracking produced by air drying the filters can be reduced by using hexamethyldisilazane
(Nation et al. A new method using hexamethyldisilazane for preparation
of soft insect tissues for scanning electron
microscopy.
Stain Tech. 58: 347-351,
1983).
The membranes were processed
in Transwell
chambers to facilitate
ease of handling.
Cutting out
the membranes prior to alcohol dehydration
causes
the membranes to roll up.
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